AbbVie Inc. (NYSE:ABBV) Stake Boosted by Regal Investment Advisors LLC

AbbVie Inc. (NYSE:ABBV) Stake Boosted by Regal Investment Advisors LLC

Regal Investment Advisors LLC boosted its position in shares of AbbVie Inc. (NYSE:ABBV – Free Report) by 2.7% in the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 114,779 shares of the company’s stock after acquiring an additional 3,032 shares during the quarter. AbbVie […]

After Tariff Flush, a Fresh Look at AbbVie Pharma (ABBV)

In my 2025 Outlook, I picked AbbVie Pharmaceuticals (NYSE: ABBV) as one to watch this year. Here is what I wrote: AbbVie (ABBV) AbbVie primarily works in immunology, oncology, neuroscience, eye care, and virology. It is also the parent company of Allergan, the maker of Botox. Botox is one of the most well-known and widely used aesthetic treatments globally, primarily known for its cosmetic use in reducing wrinkles and fine lines. Hence, it fits …

Bridgewater Associates LP Has $46.84 Million Stock Holdings in T-Mobile US, Inc. (NASDAQ:TMUS)

Bridgewater Associates LP increased its position in T-Mobile US, Inc. (NASDAQ:TMUS – Free Report) by 6.3% during the fourth quarter, Holdings Channel reports. The firm owned 212,194 shares of the Wireless communications provider’s stock after buying an additional 12,615 shares during the quarter. Bridgewater Associates LP’s holdings in T-Mobile US were worth $46,838,000 as of […]

AbbVie Inc. (NYSE:ABBV) Shares Purchased by Bridgewater Associates LP

Bridgewater Associates LP raised its position in AbbVie Inc. (NYSE:ABBV – Free Report) by 40.0% in the fourth quarter, Holdings Channel reports. The fund owned 286,363 shares of the company’s stock after buying an additional 81,791 shares during the period. Bridgewater Associates LP’s holdings in AbbVie were worth $50,887,000 as of its most recent SEC […]